首页> 外文会议>IEEE International Work Conference on Bioinspired Intelligence >A Transcriptional Regulatory Network Model Reveals miR-34a as a Potential Regulator of Proliferation in Cancer Cell Lines
【24h】

A Transcriptional Regulatory Network Model Reveals miR-34a as a Potential Regulator of Proliferation in Cancer Cell Lines

机译:转录调节网络模型揭示MIR-34A作为癌细胞系中潜在调节剂的潜在调节因子

获取原文

摘要

The genetic instability caused by the disruption of the mechanism of the DNA-damage response (DDR) has been linked to cancer development. One of the most important and studied mechanism of the DDR is the p53 pathway. This protein acts as a tumor suppressor. MDM2, MDM4 and PLK1 inhibit its proapoptotic activity by binding to its sequence-specific DNA-binding site. To model the interactions between the species with the purpose of finding key points in the regulation of proliferation in cancer cell lines, we propose a transcriptional regulatory network conformed by miRNAs, mARNs and transcription factors involved in the modulation of p53 tumor suppressor protein using Ordinary Differential Equations. Our results suggest miR-34a has a strong control in the regulation of MDM4 and its overexpression results in the decrease of the expression of this protein without significantly affecting the expression of p53. We propose that the combination of miR-34a and small molecule inhibitors of MDM2 may be a therapeutic alternative for treating cancer progression and relapse prevention.
机译:由DNA损伤反应(DDR)的机理破坏引起的遗传不稳定与癌症发育有关。 DDR最重要和研究机制之一是P53途径。该蛋白质充当肿瘤抑制剂。 MDM2,MDM4和PLK1通过与其序列特异性DNA结合位点结合来抑制其凋亡活性。为了模拟物种之间的相互作用,目的是在癌细胞系中扩散调节中的指导,我们提出了一种通过常规差分调节P53肿瘤抑制蛋白的MIRNA,MARN和转录因子的转录调节网络方程式。我们的结果表明MIR-34A在MDM4的调节中具有很强的控制,其过表达导致该蛋白表达的降低而不会显着影响P53的表达。我们提出MDM2的miR-34a和小分子抑制剂的组合可以是治疗癌症进展和复发预防的治疗替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号